- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 261/00 - Derivatives of cyanic acid
Patent holdings for IPC class C07C 261/00
Total number of patents in this class: 51
10-year publication summary
|
4
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
0
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Asahi Kasei Chemicals Corporation | 534 |
5 |
| SK Biopharmaceuticals Co., Ltd. | 277 |
4 |
| Covestro Deutschland AG | 2858 |
3 |
| ISP Investments Inc. | 441 |
2 |
| Signature Therapeutics, Inc. | 37 |
2 |
| Waters Technologies Corporation | 1815 |
2 |
| Hoffmann-La Roche Inc. | 3885 |
1 |
| BASF SE | 21337 |
1 |
| Mitsui Chemicals, Inc. | 3291 |
1 |
| Amyris, Inc. | 369 |
1 |
| Arbor Pharmaceuticals, LLC | 64 |
1 |
| Bio-Pharm Solutions Co., Ltd. | 55 |
1 |
| Cellix Bio Private Limited | 52 |
1 |
| CTC bio, Inc. | 41 |
1 |
| Daiichi Sankyo Company, Limited | 1892 |
1 |
| Emulsion Technology Co., Ltd. | 19 |
1 |
| Givaudan SA | 1985 |
1 |
| Great Eastern Resins Industrial Co., Ltd. | 7 |
1 |
| Henkel IP & Holding GmbH | 558 |
1 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 75 |
1 |
| Other owners | 19 |